##plugins.themes.academic_pro.article.main##

Abstract

Systemic lupus erythematosus is a rare complex autoimmune disease with multisystem involvement. SLE may affect all components of the respiratory system alveoli, airway, interstitum and respiratory muscle

Keywords

pulmonary manifestation Systemic lupus erythematosus HCV

##plugins.themes.academic_pro.article.details##

How to Cite
Dr. Rana Sami Hameed, Dr. Sabreen Ghazi Abed, & Dr. Mahmood Fouad Mahmood. (2023). Pulmonary Manifistation of Systemic Lupus Erthymatosus Sle. Texas Journal of Medical Science, 18, 102–108. https://doi.org/10.62480/tjms.2023.vol18.pp102-108

References

  1. Bakshi J, Segura BT, Wincup C, Rahman A. Unmet needs in the pathogenesis and treatment of systemic lupus erythematosus. Clin Rev Allergy Immunol. (2018) 55:352–67. doi: 10.1007/s12016-017-8640-5.
  2. Cuchacovich R, Gedalia A. Pathophysiology and clinical spectrum of infections in systemic lupus erythematosus. Rheum Dis Clin North Am. (2009) 35:75–93. doi: 10.1016/j.rdc.2009.03.003.
  3. Alamoudi OSB, Attar SM. Pulmonary manifestations in systemic lupus erythematosus: association with disease activity. Respirology. (2015) 20:474–80. doi: 10.1111/resp.12473.
  4. Hellman DB, Kirsch CM, Whiting-O'Keefe Q, Simonson J, Schiller NB, Petri M, et al. Dyspnea in ambulatory patients with SLE: prevalence, severity, and correlation with incremental exercise testing. J Rheumatol. (1995) 22:455–61.
  5. Nakano M, Hasegawa H, Takada T, Ito S, Muramatsu Y, Satoh M, et al. Pulmonary diffusion capacity in patients with systemic lupus erythematosus. Respirology. (2002) 7:45–9. doi: 10.1046/j.1440-1843.2002.00361.
  6. Aguilera-Pickens G, Abud-Mendoza C. Pulmonary manifestations in systemic lupus erythematosus: pleural involvement, acute pneumonitis, chronic interstitial lung disease, and diffuse alveolar hemorrhage. Reumatol Clin. (2018) 14:294–300. doi: 10.1016/j.reuma.2018.03.012.
  7. Tselios K, Urowitz MB. Cardiovascular and pulmonary manifestations of systemic lupus erythematosus. Curr Rheumatol Rev. (2017) 13:206–18. doi: 10.2174/1573397113666170704102444.
  8. Hannah JR, D'Cruz DP. Pulmonary complications of systemic lupus erythematosus. Semin Respir Crit Care Med. (2019) 40:227–34. doi: 10.1055/s-0039-1685537.
  9. Bertoli AM, Vila LM, Apte M, Fessler BJ, Bastian HM, Reveille JD, et al. Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage. Lupus. (2007) 16:410–7. doi: 10.1177/0961203307079042
  10. Kamen DL, Strange C. Pulmonary manifestations of systemic lupus erythematosus. Clin Chest Med. (2010) 31:479–88. doi: 10.1016/j.ccm.2010.05.001.
  11. Fidler L, Keen KJ, Touma Z, Mittoo S. Impact of pulmonary disease on patient-reported outcomes and patient-performed functional testing in systemic lupus erythematosus. Lupus. (2016) 25:1004–11. doi: 10.1177/0961203316630818.
  12. Mathai SC, Danoff SK. Management of interstitial lung disease associated with connective tissue disease. BMJ. (2016) 352:h6819. doi: 10.1136/bmj.h6819.
  13. Frankel SK, Brown KK. Collagen vascular diseases of the lung. Clin Pulm Med. (2006) 13:25–36.
  14. Tansey D, Wells AU, Colby TV, Ip S, Nikolakoupolou A, du Bois RM, et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology. (2004) 44:585–96.
  15. Vivero M, Padera RF. Histopathology of lung disease in the connective tissue diseases. Rheum Dis Clin North Am. (2015) 41:197–211.
  16. Koo S-M, Uh S-T. Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view. Korean J Intern Med. (2017) 32:600–10.
  17. Swigris JJ, Olson AL, Fischer A, Lynch DA, Cosgrove GP, Frankel SK, et al. Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease. Chest. (2006) 130:30–6.
  18. Wan SA, Teh CL, Jobli AT. Lupus pneumonitis as the initial presentation of systemic lupus erythematosus: case series from a single institution. Lupus. (2016) 25:1485–90.
  19. Chen YJ, Tseng JJ, Yang MJ, Tsao YP, Lin HY. Acute respiratory distress syndrome in a pregnant woman with systemic lupus erythematosus: a case report. Lupus. (2014) 23:1528–32.
  20. Glazer M, Berkman N, Lafair JS, Kramer MR. Successful talc slurry pleurodesis in patients with nonmalignant pleural effusion. Chest. (2000) 117:1404–9.
  21. Hoeper MM, Ghofrani H-A, Grünig E, Klose H, Olschewski H, Rosenkranz S. Pulmonary hypertension. Dtsch Arztebl Int. (2017) 114:73–84.
  22. Tselios K, Gladman DD, Urowitz MB. Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies. Open Access Rheumatol. (2016) 9:1–9.
  23. Johnson SR, Gladman DD, Urowitz MB, Ibañez D, Granton JT. Pulmonary hypertension in systemic lupus. Lupus. (2004) 13:506–9.